The world's first non-invasive treatment product for precancerous cervical lesions has completed its first batch of imported car shipments.

On June 5th, the world's first non-surgical non-invasive treatment product for cervical intraepithelial neoplasia grade 2 developed independently by YAHONG Pharmaceuticals - Cervitana, was officially sent to various parts of the country after the first batch of imported products completed inspection and customs clearance procedures at the Beijing port. The product is provided with medical circulation services by KeYuanXinHai Medical Supplies Trading Co., Ltd., and the first batch of products has been officially sent to distributors and medical terminals nationwide; on the same day, the world's first prescription for Cervitana was issued in Beijing.